News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
316,656 Results
Type
Article (15302)
Company Profile (292)
Press Release (301062)
Multimedia
Podcasts (48)
Webinars (7)
Section
Business (92356)
Career Advice (320)
Deals (18386)
Drug Delivery (37)
Drug Development (53033)
Employer Resources (34)
FDA (6637)
Job Trends (6359)
News (167126)
Policy (12183)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (6)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (10)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (3)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (1024)
Accelerated approval (2)
Adcomms (12)
Allergies (53)
Alliances (25510)
ALS (70)
Alzheimer's disease (916)
Antibody-drug conjugate (ADC) (101)
Approvals (6668)
Artificial intelligence (125)
Autoimmune disease (18)
Automation (7)
Bankruptcy (163)
Best Places to Work (5624)
BIOSECURE Act (8)
Biosimilars (48)
Biotechnology (238)
Bladder cancer (60)
Brain cancer (20)
Breast cancer (160)
Cancer (1533)
Cardiovascular disease (119)
Career advice (281)
Career pathing (2)
CAR-T (119)
Cell therapy (337)
Cervical cancer (9)
Clinical research (43248)
Collaboration (570)
Compensation (268)
Complete response letters (13)
COVID-19 (1097)
CRISPR (41)
C-suite (172)
Cystic fibrosis (78)
Data (1583)
Denatured (11)
Depression (32)
Diabetes (146)
Diagnostics (1876)
Digital health (5)
Diversity (2)
Diversity, equity & inclusion (10)
Drug discovery (88)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (90)
Earnings (33897)
Editorial (19)
Employer branding (6)
Employer resources (32)
Events (54885)
Executive appointments (507)
FDA (7396)
Featured Employer (33)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (543)
Gene editing (99)
Generative AI (10)
Gene therapy (255)
GLP-1 (376)
Government (1279)
Grass and pollen (2)
Guidances (23)
Healthcare (7950)
Huntington's disease (22)
IgA nephropathy (25)
Immunology and inflammation (93)
Indications (20)
Infectious disease (1168)
Inflammatory bowel disease (117)
Inflation Reduction Act (8)
Influenza (22)
Intellectual property (69)
Interviews (38)
IPO (10015)
IRA (11)
Job creations (1045)
Job search strategy (255)
Kidney cancer (7)
Labor market (5)
Layoffs (213)
Leadership (3)
Legal (2149)
Liver cancer (35)
Lung cancer (209)
Lymphoma (103)
Machine learning (3)
Management (7)
Manufacturing (152)
MASH (54)
Medical device (4182)
Medtech (4183)
Mergers & acquisitions (8835)
Metabolic disorders (406)
Multiple sclerosis (57)
NASH (13)
Neurodegenerative disease (69)
Neuropsychiatric disorders (25)
Neuroscience (1342)
NextGen: Class of 2025 (2753)
Non-profit (1079)
Northern California (1805)
Now hiring (22)
Obesity (201)
Opinion (107)
Ovarian cancer (66)
Pain (49)
Pancreatic cancer (59)
Parkinson's disease (125)
Partnered (11)
Patents (142)
Patient recruitment (80)
Peanut (37)
People (29342)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (15080)
Phase II (20010)
Phase III (12931)
Pipeline (853)
Policy (47)
Postmarket research (944)
Preclinical (6330)
Press Release (31)
Prostate cancer (65)
Psychedelics (36)
Radiopharmaceuticals (221)
Rare diseases (302)
Real estate (1899)
Recruiting (13)
Regulatory (9921)
Reports (18)
Research institute (1057)
Resumes & cover letters (35)
Rett syndrome (4)
RNA editing (5)
RSV (13)
Schizophrenia (61)
Series A (103)
Series B (66)
Service/supplier (1)
Sickle cell disease (42)
Southern California (1589)
Special edition (11)
Spinal muscular atrophy (118)
Sponsored (12)
Startups (2235)
State (2)
Stomach cancer (5)
Supply chain (28)
Tariffs (8)
The Weekly (36)
United States (14697)
Vaccines (239)
Venture capitalists (32)
Weight loss (111)
Women's health (16)
Worklife (2)
Date
Today (95)
Last 7 days (524)
Last 30 days (1663)
Last 365 days (21395)
2025 (6758)
2024 (22580)
2023 (24928)
2022 (30380)
2021 (31998)
2020 (27626)
2019 (20243)
2018 (14875)
2017 (16284)
2016 (14087)
2015 (17415)
2014 (12560)
2013 (9380)
2012 (9579)
2011 (9513)
2010 (9024)
Location
Africa (179)
Alabama (43)
Alaska (2)
Arizona (74)
Arkansas (5)
Asia (19643)
Australia (3220)
California (4125)
Canada (1195)
China (380)
Colorado (156)
Connecticut (167)
Delaware (105)
Europe (40468)
Florida (537)
Georgia (129)
Idaho (24)
Illinois (267)
India (10)
Indiana (138)
Iowa (3)
Japan (79)
Kansas (66)
Kentucky (6)
Louisiana (3)
Maine (46)
Maryland (529)
Massachusetts (3246)
Michigan (124)
Minnesota (165)
Mississippi (2)
Missouri (33)
Montana (16)
Nebraska (7)
Nevada (39)
New Hampshire (25)
New Jersey (1076)
New Mexico (13)
New York (1130)
North Carolina (700)
North Dakota (5)
Northern California (1805)
Ohio (124)
Oklahoma (9)
Oregon (22)
Pennsylvania (824)
Puerto Rico (6)
Rhode Island (20)
South America (270)
South Carolina (8)
South Dakota (1)
Southern California (1589)
Tennessee (37)
Texas (545)
Utah (76)
Virginia (90)
Washington D.C. (30)
Washington State (375)
West Virginia (2)
Wisconsin (18)
316,656 Results for "century therapeutics llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting
April 28, 2025
·
5 min read
Press Releases
Century Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
March 20, 2025
·
13 min read
Press Releases
Century Therapeutics to Host Live Fireside Chat Focused on Newly Prioritized Preclinical Cell Therapy Programs for Autoimmune Diseases and Cancer on Tuesday, April 22, 2025
April 15, 2025
·
5 min read
Press Releases
ITF Therapeutics LLC Announces Opening of New U.S. Headquarters in Concord, Massachusetts
March 5, 2025
·
6 min read
Press Releases
ITF Therapeutics LLC Announces Multiple Data Presentations at 2025 MDA Clinical and Scientific Conference
February 21, 2025
·
7 min read
Press Releases
ITF Therapeutics LLC Presents Long-Term Data of DUVYZAT™ (givinostat) for Treatment of Duchenne Muscular Dystrophy at MDA Clinical and Scientific Conference
March 18, 2025
·
7 min read
Press Releases
Century Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference
November 26, 2024
·
1 min read
Press Releases
Century Therapeutics to Present at Guggenheim’s Inaugural Healthcare Innovation Conference
November 5, 2024
·
1 min read
Business
Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
Century Therapeutics, Inc. (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology and autoimmune diseases, today reported financial results and business highlights for the first quarter ended March 31, 2024.
May 9, 2024
·
13 min read
Deals
Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics
Century Therapeutics announced plans to expand clinical development for its lead program, CNTY-101, a CD19-targeting iNK cell therapy, into additional autoimmune disease indications.
April 11, 2024
·
13 min read
1 of 31,666
Next
